Please assess the completion status of the following clinical trial:

Trial Title: An Extended Treatment Study of MT-3995 in Patients With Diabetic Nephropathy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Written informed consent for participation before the completion of MT-3995-J05 Study~* Completion of MT-3995-J05 study~Exclusion Criteria:~* UACR of ≥300 mg/g Cr with an increase of ≥30% in MT-3995-J05 Study~* Symptomatic and clinically significant hypotension~* QT prolongation or torsades de pointes~* New York Heart Association (NYHA) Class III or IV heart failure~* Patients who are judged to be unsuitable for participation based on their safety profile in MT-3995-J05 Study

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- MT-3995 Low (Type: EXPERIMENTAL): None
- MT-3995 Middle (Type: EXPERIMENTAL): None
- MT-3995 High (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).